Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chaoyi Jia"'
Autor:
Zihe Zhang, Yongwen Li, Ruifeng Shi, Chaoyi Jia, Songlin Xu, Guangsheng Zhu, Peijun Cao, Hua Huang, Xuanguang Li, Hongbing Zhang, Minghui Liu, Chen Chen, Hongyu Liu, Chunsheng Kang, Jun Chen
Publikováno v:
Cell Death and Disease, Vol 15, Iss 9, Pp 1-14 (2024)
Abstract Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (EGFR-TKI) approved for patients with EGFR T790M resistance mutations as first- or second-line treatment of EGFR-positive patients. Resistanc
Externí odkaz:
https://doaj.org/article/6cd58d2ae3984a0ea93766d76679bcb3
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 12, Pp 881-pag884e (2021)
Wegener’ granulomatosis is an autoimmune diseases, often involving the lung and kidney, has a high mortality rate in nontreatment patients. The low incidence and nonspecific features, often lead to misdiagnosis and delayed treatment. This paper rep
Externí odkaz:
https://doaj.org/article/d8a1f5d3093649568db9d0880e1dc601
Autor:
Yichun Wang, Mengting Li, Wenxia Wang, Hao Ji, Chaoyi Jia, Na Han, Huiling Li, Xiaodong Xu, Honglin Jin, Yongxue Zhang, Xiaoli Lan
Background The increasing global burden and the significant breakthroughs in malignant melanoma therapy make urgent demands on efficient response evaluation and surveillance of adverse events. Though there have been a few probes explored for early di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0029874da4ce045efc553736a8a161f
https://doi.org/10.21203/rs.3.rs-75569/v1
https://doi.org/10.21203/rs.3.rs-75569/v1
Publikováno v:
Clinical nuclear medicine. 44(6)
Giant cell tumor of tendon sheath (GCTTS) is benign mesenchymal neoplasm, and it rarely induces hypophosphatemia. We report a 49-year-old woman with suspicious tumor-induced osteomalacia underwent Ga-DOTA-TATE PET/CT to identify potential causative t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14e63768a03b59100cc14718cbe2235
https://pubmed.ncbi.nlm.nih.gov/30932980
https://pubmed.ncbi.nlm.nih.gov/30932980
Autor:
Wenhao Zhao1, Hua Huang1, Zexia Zhao1, Chen Ding1, Chaoyi Jia1, Yingjie Wang1, Guannan Wang1, Yongwen Li2, Hongyu Liu2 liuhongyu123@hotmail.com, Jun Chen1,2 huntercj2004@qq.com
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 14, p4513-4526. 14p.
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 2, Iss 4, Pp 411-420 (2012)
The present work was focused on the study of the three-dimensional (3D) structural requirements for the highly potent bioactivity of dipeptidyl peptidase (DPP) IV's inhibitor. At first, molecular dynamic and mechanic (MD/MM) simulations were performe
Externí odkaz:
https://doaj.org/article/efa21897825d4c41815c1763359e8655